A review of acrylamide neurotoxicity. Part I. Properties, uses and human exposure.
D000178:Acrylamides / Q000378:metabolism / Q000494:pharmacology / Q000506:poisoning / Q000633:toxicity*; D000208:Acute Disease; D000818:Animals; D002617:Chemical Industry; D002908:Chronic Disease; D004576:Electromyography; D004781:Environmental Exposure; D006801:Humans; D009410:Nerve Degeneration; D009419:Nerve Tissue Proteins / Q000096:biosynthesis; D009431:Neural Conduction; D009784:Occupational Diseases / Q000517:prevention & control; D010215:Papio; D010525:Peripheral Nerves / Q000473:pathology; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced* / Q000473:pathology; D011041:Poisoning / Q000175:diagnosis / Q000517:prevention & control; D011485:Protein Binding; D012877:Skin Manifestations
D000178:Acrylamides; D009419:Nerve Tissue Proteins